Journal of Bone and Mineral Metabolism最新文献

筛选
英文 中文
Back extensor strength and incident GERD in women receiving osteoporosis treatment: a retrospective cohort study. 在接受骨质疏松治疗的女性中,腰伸肌力量和胃反流的发生率:一项回顾性队列研究。
IF 2.9 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2026-11-07 DOI: 10.1007/s00774-026-01781-5
Hiromichi Abe, Yuichi Ono, Yuji Kasukawa, Hiroyuki Tsuchie, Michio Hongo, Naohisa Miyakoshi
{"title":"Back extensor strength and incident GERD in women receiving osteoporosis treatment: a retrospective cohort study.","authors":"Hiromichi Abe, Yuichi Ono, Yuji Kasukawa, Hiroyuki Tsuchie, Michio Hongo, Naohisa Miyakoshi","doi":"10.1007/s00774-026-01781-5","DOIUrl":"https://doi.org/10.1007/s00774-026-01781-5","url":null,"abstract":"<p><strong>Introduction: </strong>We investigated factors associated with incident gastroesophageal reflux disease (GERD) in women receiving osteoporosis treatment.</p><p><strong>Materials and methods: </strong>This retrospective cohort study included 82 women with osteoporosis, baseline Frequency Scale for the Symptoms of GERD (FSSG) scores < 8, and an available follow-up assessment at least 4 years later. Incident questionnaire-defined GERD was defined as a final follow-up FSSG score ≥ 8 among participants with baseline scores < 8. Clinical characteristics, radiographic parameters, bone mineral density (BMD), body composition, and muscle strength were compared between groups. Separate age-adjusted logistic regression models assessed follow-up back extensor strength and percentage changes in back extensor strength and lumbar spine BMD expressed as a percentage of the young adult mean (%YAM).</p><p><strong>Results: </strong>At the final follow-up assessment, 19 participants (23.2%) were classified as GERD-positive. Follow-up back extensor strength was lower in the GERD group (10.6 ± 4.5 vs 14.3 ± 5.7 kg; p = 0.011). Higher follow-up back extensor strength was associated with lower odds of incident GERD (age-adjusted odds ratio, 0.86 per 1-kg increase; 95% confidence interval, 0.76-0.98; p = 0.019). Neither percentage change was significantly associated with incident GERD. BMD increased during follow-up, and radiographic parameters did not differ significantly between groups.</p><p><strong>Conclusion: </strong>Lower back extensor strength at follow-up was associated with questionnaire-defined GERD in women receiving osteoporosis treatment. Although temporal and causal relationships remain uncertain, prospective studies with strength assessments before symptom onset could clarify this association and inform future trials of back extensor strengthening.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149370744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of risk factors underlying a decline in gait speed in older individuals. 识别老年人步态速度下降的危险因素。
IF 2.9 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2026-11-04 DOI: 10.1007/s00774-026-01779-z
Mitsunobu Yonemura, Yuko Fukuma, Keisuke Takahashi, Takehiro Koga, Masaru Uragami, Kazuhiro Yoshiura, Naoto Kajitani, Minoru Takebayashi, Takeshi Miyamoto
{"title":"Identification of risk factors underlying a decline in gait speed in older individuals.","authors":"Mitsunobu Yonemura, Yuko Fukuma, Keisuke Takahashi, Takehiro Koga, Masaru Uragami, Kazuhiro Yoshiura, Naoto Kajitani, Minoru Takebayashi, Takeshi Miyamoto","doi":"10.1007/s00774-026-01779-z","DOIUrl":"https://doi.org/10.1007/s00774-026-01779-z","url":null,"abstract":"<p><strong>Introduction: </strong>Declining gait speed is strongly associated with future long-term care (LTC) dependency in older adults; however, its risk factors remain unclear. This study aimed to identify predictors of gait speed decline and develop a simple risk scoring system.</p><p><strong>Materials and methods: </strong>A total of 1,577 community-dwelling adults aged ≥65 years were followed for 6 years. Of the 725 participants followed, 37 with baseline gait speed <1 m/s were excluded, leaving 688 for cohort analysis. Among these, 98 baseline factors were initially examined, and five predictors were selected. Complete data were available for 681 participants (91 with and 590 without gait speed decline). The five predictors were entered simultaneously into a multivariable logistic regression model, and a scoring system was developed based on the regression coefficients.</p><p><strong>Results: </strong>The five predictors were age, pain/discomfort, mobility problems, exercise <3 days/week, and not feeling full of energy. The apparent AUC of the logistic model was 0.735 (95% CI 0.678-0.792), and the optimism-corrected AUC after 1,000 bootstrap resamples was 0.714. A revised integer score based on the mutually adjusted coefficients ranged from 0 to 18 points. A cutoff of ≥6 points yielded a sensitivity of 0.505, specificity of 0.847, positive predictive value of 0.338, negative predictive value of 0.918, and score AUC of 0.736 (95% CI 0.676-0.795).</p><p><strong>Conclusions: </strong>We developed a simple scoring system to predict gait speed decline in older adults. Currently, it should be considered an exploratory risk stratification tool; external validation may support its future clinical use.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149334035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteoporosis, sarcopenia, locomotive syndrome, and frailty in age-related spinal kyphosis. 骨质疏松症、肌肉减少症、运动综合征和老年性脊柱后凸的虚弱。
IF 2.9 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2026-11-01 DOI: 10.1007/s00774-026-01774-4
Shinji Tanishima, Takashi Wada, Hideki Nagashima
{"title":"Osteoporosis, sarcopenia, locomotive syndrome, and frailty in age-related spinal kyphosis.","authors":"Shinji Tanishima, Takashi Wada, Hideki Nagashima","doi":"10.1007/s00774-026-01774-4","DOIUrl":"https://doi.org/10.1007/s00774-026-01774-4","url":null,"abstract":"<p><strong>Introduction: </strong>Age-related kyphosis is a common manifestation of musculoskeletal aging associated with falls, mobility decline, reduced participation, and respiratory compromise in severe cases. This narrative review summarizes its relationships with osteoporosis, sarcopenia, locomotive syndrome, and frailty.</p><p><strong>Materials and methods: </strong>PubMed/MEDLINE was searched for English-language publications from database inception through December 31, 2025. Relevant evidence was reviewed narratively.</p><p><strong>Results: </strong>Observational studies indicate that osteoporosis-associated vertebral fragility is an important structural contributor to kyphotic progression through clinically apparent or unrecognized vertebral fractures and progressive vertebral deformity. Degenerative disc changes and local trunk muscle dysfunction may also contribute through altered spinal loading and reduced active postural support. Evidence linking generalized sarcopenia to kyphosis remains inconsistent, whereas local trunk muscle dysfunction and poor paraspinal muscle quality may be more directly relevant. Kyphosis may coexist with locomotive syndrome and physical frailty, but these associations do not establish causality.</p><p><strong>Conclusion: </strong>Assessment should include bone mineral density, vertebral fracture status, regional and global sagittal alignment, trunk muscle function, and mobility. Management should combine appropriate osteoporosis treatment, trunk-focused exercise, posture training, and nutritional support. Further longitudinal and interventional studies are needed to clarify causal relationships and determine whether treatment preserves mobility and independence.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149321474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular safety of romosozumab versus alendronate in postmenopausal women with severe osteoporosis: a propensity-matched real-world study. romosozumab与阿仑膦酸钠在绝经后严重骨质疏松症妇女中的心血管安全性:一项倾向匹配的现实世界研究
IF 2.9 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2026-10-30 DOI: 10.1007/s00774-026-01775-3
Gizem Teker, Sara Ramadan, Ali Emre Bardak, Sezan Vehbi, Smuch Siramongkholkarn, Zhiheng He
{"title":"Cardiovascular safety of romosozumab versus alendronate in postmenopausal women with severe osteoporosis: a propensity-matched real-world study.","authors":"Gizem Teker, Sara Ramadan, Ali Emre Bardak, Sezan Vehbi, Smuch Siramongkholkarn, Zhiheng He","doi":"10.1007/s00774-026-01775-3","DOIUrl":"https://doi.org/10.1007/s00774-026-01775-3","url":null,"abstract":"<p><strong>Background: </strong>Romosozumab is highly effective for severe osteoporosis, but its cardiovascular safety is debated. The ARCH trial found more major adverse cardiovascular events (MACE) with romosozumab than with alendronate, whereas the placebo-controlled FRAME trial found no signal. Real-world head-to-head data against alendronate are lacking.</p><p><strong>Materials and methods: </strong>Using the TriNetX U.S. Collaborative Network, we identified women aged ≥55 years with severe osteoporosis (pathological, lumbar vertebral, or hip fracture within 2 years) who initiated romosozumab or alendronate, excluding those with any MACE in the prior 12 months. Cohorts were matched 1:1 by propensity score on demographics, cardiovascular comorbidities, medications, and laboratory parameters, and followed for 12 months. The primary outcome was a composite of MACE; secondary outcomes were myocardial infarction (MI), acute coronary syndrome (ACS), and ischemic stroke. Hazard ratios (HRs) were estimated using Cox models.</p><p><strong>Results: </strong>After matching, 5930 women remained per group (mean age 72 years; median follow-up 365 days). Romosozumab was not associated with an increased risk of MACE (HR 0.87; 95% CI 0.70-1.07), MI (HR 0.92; 95% CI 0.67-1.28), or ACS (HR 0.97; 95% CI 0.72-1.32). Ischemic stroke was significantly lower with romosozumab (HR 0.64; 95% CI 0.46-0.89; P=0.008). Findings were consistent in event-naïve analyses and across subgroups, including chronic kidney disease and diabetes; however, the advanced-CKD stratum (stage 4-5 or end-stage renal disease) could not be analyzed because event counts were too small for estimation.</p><p><strong>Conclusion: </strong>In postmenopausal women with severe osteoporosis, romosozumab was not associated with higher 12-month cardiovascular risk than alendronate. These findings are reassuring in the populations that could be evaluated, although cardiovascular safety in advanced CKD remains uncertain and prospective confirmation is warranted.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhalant allergy is associated with bone parameters in young adults: a sex-specific analysis using ultrasound. 吸入剂过敏与年轻人骨骼参数相关:一项使用超声的性别特异性分析。
IF 2.9 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2026-10-27 DOI: 10.1007/s00774-026-01777-1
Alexandra Hozáková, Darina Falbová, Simona Sulis, Lenka Vorobeľová
{"title":"Inhalant allergy is associated with bone parameters in young adults: a sex-specific analysis using ultrasound.","authors":"Alexandra Hozáková, Darina Falbová, Simona Sulis, Lenka Vorobeľová","doi":"10.1007/s00774-026-01777-1","DOIUrl":"https://doi.org/10.1007/s00774-026-01777-1","url":null,"abstract":"<p><strong>Introduction: </strong>To examine, separately by sex, whether inhalant allergy is associated with peripheral bone status assessed by quantitative ultrasonography (QUS) in Slovak young adults.</p><p><strong>Materials and methods: </strong>We analysed 649 adults aged 18-30 years (393 women, 256 men), classified as inhalant allergy (IA; 200 women, 114 men), other non-inhalant allergy (OA; 12 women, 9 men), or no allergy (NA; 181 women, 133 men). Speed of sound (SOS) and Z-scores were measured at the radius using the Sunlight MiniOmni (BeamMed, Israel). Group differences were analysed using Welch's ANOVA with Games-Howell tests. Multiple linear regression assessed associations across four models (base, lifestyle-adjusted, current-treatment-adjusted, and past-treatment-adjusted), and combined models tested interactions between inhalant allergy group and sex.</p><p><strong>Results: </strong>In men, Z-score differed across groups (p = 0.042), with lower values in IA than NA (- 0.502 ± 0.943 vs. - 0.187 ± 0.854; p = 0.019). IA was associated with lower Z-scores across all models (β = - 0.325 to - 0.365; p ≤ 0.021) and lower SOS in three models (β = - 0.260 to - 0.308; p ≤ 0.036). Reduced Z-score was more frequent in IA than NA men (6.1% vs. 0.8%; p = 0.026). In women, IA was associated with higher Z-scores across all models (p = 0.037-0.048), but not with SOS or reduced Z-score. IA-by-sex interactions were significant for both outcomes across all models.</p><p><strong>Conclusion: </strong>Findings suggest a sex-specific association between inhalant allergy and QUS-derived bone parameters, with less favourable peripheral bone status in men and no adverse pattern in women. Further research is warranted.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149287016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Denosumab, clinical fractures, and osteonecrosis of the jaw in hemodialysis patients: a comparative study. Denosumab,血液透析患者临床骨折和颌骨骨坏死:一项比较研究。
IF 2.9 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2026-10-26 DOI: 10.1007/s00774-026-01773-5
Tatsunori Toida, Noriaki Kurita, Akihito Fujita, Ryoji Tominaga, Ryohei Inanaga, Masataka Taguri, Tatsuyoshi Ikenoue
{"title":"Denosumab, clinical fractures, and osteonecrosis of the jaw in hemodialysis patients: a comparative study.","authors":"Tatsunori Toida, Noriaki Kurita, Akihito Fujita, Ryoji Tominaga, Ryohei Inanaga, Masataka Taguri, Tatsuyoshi Ikenoue","doi":"10.1007/s00774-026-01773-5","DOIUrl":"https://doi.org/10.1007/s00774-026-01773-5","url":null,"abstract":"<p><strong>Introduction: </strong>Comparative effectiveness of denosumab versus bisphosphonates for overall fracture risk and medication-related osteonecrosis of the jaw (MRONJ) in patients on hemodialysis remains unclear. We compared fracture outcomes and MRONJ using linked medical-dental claims.</p><p><strong>Materials and methods: </strong>We used the DeSC Healthcare Database to identify patients on hemodialysis with osteoporosis or prior fragility fractures prescribed denosumab or bisphosphonates from March 2015 to August 2022. Separate prevalent-user (ongoing users) and new-user (treatment initiators) cohorts were constructed. The primary outcome was all clinical fractures, including first and subsequent events; secondary outcomes were first clinical, hip, vertebral, and other fractures. The safety outcome was first MRONJ. IPTW-weighted Cox models estimated hazard ratios with 95% confidence intervals.</p><p><strong>Results: </strong>Among 2379 prevalent-user and 1024 new-user records, mean age was 79 years, and 30-40% had a history of clinical fractures. In the prevalent-user cohort, denosumab was associated with a lower incidence of all clinical fractures than bisphosphonates. Point estimates for first-fracture outcomes generally favored denosumab but were imprecise. In the new-user cohort, the point estimates were generally similar in direction, but the results were not statistically significant. First MRONJ incidence was 0.31 and 0.65 per 100 person-years in the bisphosphonate and denosumab groups, respectively, without statistical significance.</p><p><strong>Conclusion: </strong>In the prevalent-user cohort, denosumab was associated with a lower incidence of all clinical fractures than bisphosphonates, whereas first-fracture associations and the new-user analysis were imprecise. These findings and the low incidence of MRONJ may inform shared decision-making regarding antiresorptive therapies.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149267725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between remaining teeth and femoral neck bone mineral density in patients undergoing dialysis. 透析患者剩余牙齿与股骨颈骨密度的关系。
IF 2.9 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2026-10-26 DOI: 10.1007/s00774-026-01771-7
Kunio Yoshizawa, Ayako Chino, Makiko Konishi, Ayumu Nakashima, Hiroyuki Morisaka, Hiroshi Yokomichi, Malek Abdelghafaar, Akinori Moroi, Koichiro Ueki
{"title":"Association between remaining teeth and femoral neck bone mineral density in patients undergoing dialysis.","authors":"Kunio Yoshizawa, Ayako Chino, Makiko Konishi, Ayumu Nakashima, Hiroyuki Morisaka, Hiroshi Yokomichi, Malek Abdelghafaar, Akinori Moroi, Koichiro Ueki","doi":"10.1007/s00774-026-01771-7","DOIUrl":"https://doi.org/10.1007/s00774-026-01771-7","url":null,"abstract":"<p><strong>Introduction: </strong>Assessing bone mineral density and implementing fracture prevention measures are useful in managing dialysis patients. This study aimed to assess oral health, including the number of remaining teeth, and to investigate factors associated with the young adult mean (%YAM) of the femur and lumbar spine in this population.</p><p><strong>Materials and methods: </strong>This cross-sectional study included 110 patients who initiated dialysis treatment at our hospital and underwent panoramic radiography, oral assessments and dual-energy X-ray absorptiometry (DXA) scans of the femur and lumbar spine within one month. Associations between oral health and YAM were examined using univariate and multivariable analyses, with the latter focusing on femoral YAM because of potential artefacts affecting lumbar measurements.</p><p><strong>Results: </strong>In the univariate analysis, femoral YAM was significantly associated with sex (B = -21.62, p < 0.001), body mass index (BMI; B = 1.926, p < 0.001), and the number of remaining teeth (B = 0.388, p = 0.026). However, in the multivariable analysis, the final model did not include the number of remaining teeth. BMI (B = 1.12, p = 0.005) and sex (B = -18.49, p < 0.001) remained significant factors, with sex showing the strongest association.</p><p><strong>Conclusion: </strong>In incident dialysis patients, fewer remaining teeth were associated with lower femoral YAM in univariate analysis, but this association was not independent of age, sex and BMI in multivariable analysis. Tooth loss may therefore reflect the cumulative effects of these factors rather than representing an independent predictor of bone mineral density.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149267673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Propionibacterium cheese and bone turnover in active young adults: a randomized-controlled trial. 丙酸杆菌奶酪和活跃年轻人的骨转换:一项随机对照试验。
IF 2.9 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2026-10-09 DOI: 10.1007/s00774-026-01761-9
Helge Einar Lundberg, Stig Larsen, Therese Fostervold Mathisen, Tove Tveitan Borgen, Jorunn Sundgot-Borgen
{"title":"Propionibacterium cheese and bone turnover in active young adults: a randomized-controlled trial.","authors":"Helge Einar Lundberg, Stig Larsen, Therese Fostervold Mathisen, Tove Tveitan Borgen, Jorunn Sundgot-Borgen","doi":"10.1007/s00774-026-01761-9","DOIUrl":"https://doi.org/10.1007/s00774-026-01761-9","url":null,"abstract":"<p><strong>Introduction: </strong>Young physically active individuals exposed to prolonged physiological stress and low energy availability are prone to reduced gonadal steroid protection and increased bone turnover. Nutritional strategies that favor positive bone remodeling balance are of clinical interest. Jarlsberg cheese contains Propionibacterium freudenreichii (PF), which produces vitamin K₂ and 1,4-dihydroxy-2-naphthoic acid (DHNA), compounds with potential favorable effects on bone health.</p><p><strong>Materials and methods: </strong>In this 24-week sex-stratified randomized-controlled trial, 60 young physically active adults engaged in endurance training were allocated to daily intake of either Jarlsberg cheese or a nutritionally comparable control cheese without PF. The primary outcome was change in serum total osteocalcin (tOC). Secondary outcomes were changes in carboxylated osteocalcin (cOC), procollagen type 1 N-terminal propeptide (P1NP), cross-linked C-terminal telopeptide of type I collagen (CTX), P1NP/CTX ratio, lumbar spine bone mineral density (BMD), and trabecular bone score (TBS).</p><p><strong>Results: </strong>After 24 weeks, serum tOC was significantly higher in the Jarlsberg group than in controls (38.0 vs. 26.8 ng/mL, p < 0.01). cOC and P1NP/CTX ratio increased in favor of the Jarlsberg group (p = 0.03). Lumbar spine BMD increased in the Jarlsberg group (mean change 0.012 g/cm<sup>2</sup>, p = 0.03), with a greater increase than in controls (p = 0.05), and TBS showed a positive trend in the Jarlsberg group.</p><p><strong>Conclusion: </strong>Daily intake of cheese-containing PF was associated with favorable changes in bone turnover markers and increase in lumbar spine BMD. These findings suggest that PF-fermented cheese may support bone metabolism in young individuals exposed to reduced hormonal protection and high bone turnover.</p><p><strong>Protocol number: </strong>XCS-Jarlsberg/IIA.</p><p><strong>Clinicaltrials: </strong>GOV: NCT06688032.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149148007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute-phase reaction and fracture outcomes from zoledronic acid: a systematic review and meta-analysis. 唑来膦酸的急性期反应和骨折结局:一项系统回顾和荟萃分析。
IF 2.9 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2026-10-06 DOI: 10.1007/s00774-026-01751-x
Masaki Takigawa, Kazumasa Kotake, Takahiro Tsuge, Akihiro Saitsu, Yuichi Isaji, Shunsuke Kondo, Tomoki Maruyama, Norio Yamamoto
{"title":"Acute-phase reaction and fracture outcomes from zoledronic acid: a systematic review and meta-analysis.","authors":"Masaki Takigawa, Kazumasa Kotake, Takahiro Tsuge, Akihiro Saitsu, Yuichi Isaji, Shunsuke Kondo, Tomoki Maruyama, Norio Yamamoto","doi":"10.1007/s00774-026-01751-x","DOIUrl":"https://doi.org/10.1007/s00774-026-01751-x","url":null,"abstract":"<p><strong>Introduction: </strong>Zoledronic acid (ZOL), an intravenous bisphosphonate used to treat osteoporosis, is frequently associated with the development of an acute-phase reaction (APR). Although some studies have reported that the APR may correlate with fracture outcomes, the evidence remains inconsistent. This systematic review and meta-analysis aimed to investigate the association between the occurrence of an APR and fracture outcomes following ZOL therapy.</p><p><strong>Materials and methods: </strong>We searched MEDLINE, EMBASE, CENTRAL, International Clinical Trials Registry Platform, and ClinicalTrials.gov through April 2025 for observational studies and secondary analyses of randomized controlled trials in adults with osteoporosis. The primary outcome was the incidence of osteoporotic fractures. Secondary outcomes were mortality and changes in bone mineral density (BMD) and bone turnover markers (BTMs). The meta-analyses were performed using random-effects models and the certainty of evidence was assessed using the GRADE approach.</p><p><strong>Results: </strong>Seven studies were included in the final analysis. No significant association was observed between APR and fracture risk (all fractures: odds ratio (OR) 0.79, 95% confidence interval (CI) 0.19-3.26; vertebral fractures: OR 0.76, 95%CI 0.17-3.32). Similarly, no significant association was found between developing an APR and all-cause mortality, or changes in BMD, or BTMs. The certainty of the evidence ranged from very low to moderate.</p><p><strong>Conclusion: </strong>Current evidence is insufficient to establish a clear association between ZOL-induced APR and fracture risk, mortality, or BMD outcomes among patients with osteoporosis. To accurately capture potential associations, future large-scale prospective studies should enroll high-risk patients, including bisphosphonate-naïve individuals, and evaluate baseline BTMs and short-term mortality.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149110196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with improved quality of life in severe osteoporosis: a post hoc analysis of JOINT-05. 与严重骨质疏松患者生活质量改善相关的因素:JOINT-05的事后分析
IF 2.9 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2026-10-06 DOI: 10.1007/s00774-026-01764-6
Hiroyuki Inose, Satoshi Mori, Hiroshi Hagino, Satoshi Soen
{"title":"Factors associated with improved quality of life in severe osteoporosis: a post hoc analysis of JOINT-05.","authors":"Hiroyuki Inose, Satoshi Mori, Hiroshi Hagino, Satoshi Soen","doi":"10.1007/s00774-026-01764-6","DOIUrl":"https://doi.org/10.1007/s00774-026-01764-6","url":null,"abstract":"<p><strong>Introduction: </strong>The goal of modern osteoporosis management is to prevent fractures and preserve patient quality of life (QOL). However, factors associated with changes in QOL during treatment, particularly for patients with severe osteoporosis, are not well understood. This study aimed to identify clinical and biochemical factors associated with the magnitude of QOL improvement in this high-risk population.</p><p><strong>Materials and methods: </strong>This was a post hoc analysis of data from the Japan Osteoporosis Intervention Trial-05 (JOINT-05). The analysis included 612 women with severe osteoporosis, with a mean age of 81.3 years. The primary endpoint was the change in the EuroQol-5 dimensions (EQ-5D) utility score over 72 weeks. Potential baseline factors included patient demographics, oral health status (number of remaining teeth), low back pain intensity (visual analog scale, VAS), and biochemical markers. Factors associated with QOL change were evaluated using exploratory regression analyses and a clinically informed multivariable linear regression model.</p><p><strong>Results: </strong>Following the treatment period, mean QOL scores improved significantly. In the clinically informed multivariable model, baseline EQ-5D, number of remaining teeth, serum tartrate-resistant acid phosphatase 5b levels, and corrected urinary pentosidine levels were independently associated with the change in EQ-5D from baseline to 72 weeks.</p><p><strong>Conclusion: </strong>This study identified several clinical and biochemical factors associated with QOL improvement in patients undergoing treatment for severe osteoporosis. These findings suggest that baseline QOL, oral health status, and biochemical markers of bone turnover and bone quality may be associated with QOL improvement during osteoporosis treatment. Further studies are needed to validate these exploratory findings.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149110199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书